Morning Headlines 9/16/24
Ozempic Is Selling So Well An Insurer Wants $1 Million In Payments Back
Elevance Health’s Anthem Blue Cross Blue Shield accuses physicians of falsifying patient medical records with the intention of getting the insurer to pay for improper prescribing of the diabetes drug Ozempic for weight loss, a use that is not approved by the FDA.
Phishing Email May Have Impacted Personal Information
Atrium Health notifies patients that an unauthorized third party gained access to multiple employee email accounts in a two-day phishing attack.
Nirvana Raises $24.2M Series A to Revolutionize Health Insurance Verification
Nirvana, a New York City-based startup specializing in AI-powered health insurance verification software, raises $24.2 million.
23andMe settles data breach lawsuit for $30 million
23andMe will pay $30 million to settle a lawsuit that accused the company of failing to protect the records of 6.9 million of its users whose information was exposed in a 2023 breach.
Thank you for writing "homogeneous" instead of "homogenous".